The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-amino-N-(1-(3-chloro-5-cyanopyridin-2-yl)azetidin-3-yl)-2,3-dimethyl-2H-indazole-5-carboxamide ID: ALA4635732
PubChem CID: 156013904
Max Phase: Preclinical
Molecular Formula: C19H18ClN7O
Molecular Weight: 395.85
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1c2c(N)c(C(=O)NC3CN(c4ncc(C#N)cc4Cl)C3)ccc2nn1C
Standard InChI: InChI=1S/C19H18ClN7O/c1-10-16-15(25-26(10)2)4-3-13(17(16)22)19(28)24-12-8-27(9-12)18-14(20)5-11(6-21)7-23-18/h3-5,7,12H,8-9,22H2,1-2H3,(H,24,28)
Standard InChI Key: GDCYKVJHXHNICW-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
35.7250 -12.2771 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.4347 -11.8676 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.4318 -11.0450 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.7232 -10.6397 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.0170 -11.8681 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.0182 -11.0516 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2420 -10.7980 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.7610 -11.4580 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.2400 -12.1192 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.9907 -10.0205 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.9438 -11.4568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.7195 -9.8225 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.1380 -10.6337 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.8473 -11.0396 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.1349 -9.8165 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
38.5534 -10.6284 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.3468 -10.8389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.5554 -10.0488 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.7652 -9.8402 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.2602 -9.6389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.9697 -10.0465 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
41.6754 -9.6359 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.6728 -8.8179 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.9586 -8.4121 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.2558 -8.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.5455 -8.4211 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
42.3769 -8.4032 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.0825 -7.9910 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5 1 1 0
1 2 2 0
2 3 1 0
3 4 2 0
4 6 1 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 1 0
9 5 2 0
7 10 1 0
8 11 1 0
4 12 1 0
3 13 1 0
13 14 1 0
13 15 2 0
14 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 16 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
18 20 1 0
25 26 1 0
27 28 3 0
23 27 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 395.85Molecular Weight (Monoisotopic): 395.1261AlogP: 2.00#Rotatable Bonds: 3Polar Surface Area: 112.86Molecular Species: NEUTRALHBA: 7HBD: 2#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 2.65CX LogP: 2.51CX LogD: 2.51Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.66Np Likeness Score: -1.75
References 1. Temple KJ, Long MF, Engers JL, Watson KJ, Chang S, Luscombe VB, Rodriguez AL, Niswender CM, Bridges TM, Conn PJ, Engers DW, Lindsley CW.. (2020) Discovery of structurally distinct tricyclic M4 positive allosteric modulator (PAM) chemotypes., 30 (4): [PMID:31787491 ] [10.1016/j.bmcl.2019.126811 ]